Table 3 Univariate and multivariate logistic regression analyses of independent risk factors for development AMI in diabetic patients
Univariate | Multivariate | |||
|---|---|---|---|---|
OR (95% CI) | P value | Adjusted OR (95% CI) | P value | |
12–13-diHOME | 1.414 (1.260–1.586) | < 0.001 | 1.456 (1.184–1.791) | < 0.001 |
Norepinephrine | 5.427 (2.773–10.622) | < 0.001 | 9.787 (2.412–39.723) | 0.001 |
Age | 1.006 (0.981–1.032) | 0.646 | ||
Male gender | 3.596 (2.110–6.127) | < 0.001 | ||
Smoking | 0.147 (0.083–0.262) | < 0.001 | 0.110 (0.021–0.583) | 0.009 |
Hypertension | 0.282 (0.167–0.476) | 0.001 | 0.065 (0.016–0.265) | < 0.001 |
Cr, umol/L | 1.020 (1.007–1.032) | 0.002 | ||
TC, mmol/L | 1.588 (1.221–2.065) | 0.001 | ||
HDL-C, mmol/L | 0.250 (0.081–0.770) | 0.016 | ||
LDL-C, mmol/L | 2.182 (1.497–3.181) | < 0.001 | ||
Hs-CRP, mg/L | 1.101 (1.065–1.138) | < 0.001 | 1.106 (1.046–1.169) | < 0.001 |
HbA1c | 1.720 (1.394–2.121) | < 0.001 | ||
Fasting glucose, mmol/L | 1.520 (1.332–1.734) | < 0.001 | 1.388 (1.053–1.829) | 0.02 |
Statin | 5.093 (2.533–10.239) | < 0.001 | ||
ACEI/ARB | 2.408 (1.424–4.072) | 0.001 | 10.758 (2.454–47.171) | 0.002 |
Diuretics | 2.695 (1.612–4.504) | < 0.001 | 8.248 (2.362–28.799) | 0.001 |